These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3561892)

  • 21. Inhibition of diabetes-associated complications by nucleophilic compounds.
    Kumari K; Umar S; Bansal V; Sahib MK
    Diabetes; 1991 Aug; 40(8):1079-84. PubMed ID: 1907249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quick, simple method for detecting circulating fluorescent advanced glycation end-products: Correlation with in vitro and in vivo non-enzymatic glycation.
    Villa M; Parravano M; Micheli A; Gaddini L; Matteucci A; Mallozzi C; Facchiano F; Malchiodi-Albedi F; Pricci F
    Metabolism; 2017 Jun; 71():64-69. PubMed ID: 28521879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes.
    McLean WG; Pekiner C; Cullum NA; Casson IF
    Mol Neurobiol; 1992; 6(2-3):225-37. PubMed ID: 1476675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.
    Poduslo JF; Curran GL
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2218-22. PubMed ID: 1549585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating glycated albumin and glomerular anionic charges.
    Londoño I; Gingras D; Bendayan M
    Exp Diabesity Res; 2003; 4(2):83-92. PubMed ID: 14630570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.
    McRobert EA; Gallicchio M; Jerums G; Cooper ME; Bach LA
    J Biol Chem; 2003 Jul; 278(28):25783-9. PubMed ID: 12734202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use and time relationship of changes in affinity measurement of glycosylated albumin and glycosylated hemoglobin.
    Rendell M; Paulsen R; Eastberg S; Stephen PM; Valentine JL; Smith CH; Nierenberg J; Rasbold K; Klenk D; Smith PK
    Am J Med Sci; 1986 Jul; 292(1):11-4. PubMed ID: 3717201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus.
    Mariee AD; Al-Shabanah O
    J Pharm Biomed Anal; 2006 May; 41(2):571-5. PubMed ID: 16469467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of maltol in advanced glycation end products and free radicals: in-vitro and in-vivo studies.
    Kang KS; Yamabe N; Kim HY; Yokozawa T
    J Pharm Pharmacol; 2008 Apr; 60(4):445-52. PubMed ID: 18380916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of 14C-glycated albumin from serum of rabbit.
    Kallner A
    Scand J Clin Lab Invest; 1990 Nov; 50(7):763-8. PubMed ID: 2293337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells.
    Amore A; Cirina P; Mitola S; Peruzzi L; Gianoglio B; Rabbone I; Sacchetti C; Cerutti F; Grillo C; Coppo R
    Kidney Int; 1997 Jan; 51(1):27-35. PubMed ID: 8995714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.
    Ibrahim AS; El-Remessy AB; Matragoon S; Zhang W; Patel Y; Khan S; Al-Gayyar MM; El-Shishtawy MM; Liou GI
    Diabetes; 2011 Apr; 60(4):1122-33. PubMed ID: 21317295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy.
    Ziyadeh FN; Cohen MP
    Mol Cell Biochem; 1993 Aug; 125(1):19-25. PubMed ID: 8264568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes.
    Bhonsle HS; Korwar AM; Kote SS; Golegaonkar SB; Chougale AD; Shaik ML; Dhande NL; Giri AP; Shelgikar KM; Boppana R; Kulkarni MJ
    J Proteome Res; 2012 Feb; 11(2):1391-6. PubMed ID: 22181049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrazine-conjugated cellulose for adsorption of glycated proteins.
    Kojima S; Ogino E; Tani N
    Ther Apher; 1999 May; 3(2):186-9. PubMed ID: 10341395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate regulated transendothelial transport of proteins.
    Williams SK; Rose DG
    Adv Exp Med Biol; 1988; 242():179-83. PubMed ID: 3245510
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo.
    Rendell M; Nierenberg J; Brannan C; Valentine JL; Stephen PM; Dodds S; Mercer P; Smith PK; Walder J
    J Lab Clin Med; 1986 Oct; 108(4):286-93. PubMed ID: 3760670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis.
    Lamb E; Cattell WR; Dawnay A
    Clin Sci (Lond); 1993 Jun; 84(6):619-26. PubMed ID: 8334808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycated albumin stimulates fibronectin and collagen IV production by glomerular endothelial cells under normoglycemic conditions.
    Cohen MP; Wu VY; Cohen JA
    Biochem Biophys Res Commun; 1997 Oct; 239(1):91-4. PubMed ID: 9345275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.